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We describe the first reported transmission to a human
of simian foamy virus (SFV) from a free-ranging population
of nonhuman primates in Asia. The transmission of an
exogenous retrovirus, SFV, from macaques (Macaca fasci-
cularis) to a human at a monkey temple in Bali, Indonesia,
was investigated with molecular and serologic techniques.
Antibodies to SFV were detected by Western blotting of
serum from 1 of 82 humans tested. SFV DNA was detect-
ed by nested polymerase chain reaction (PCR) from the
blood of the same person. Cloning and sequencing of PCR
products confirmed the virus’s close phylogenetic relation-
ship to SFV isolated from macaques at the same temple.
This study raises concerns that persons who work at or live
around monkey temples are at risk for infection with SFV.
R
ecent epidemics such as HIV and severe acute respira-
tory syndrome (SARS) have changed the way we
view emerging infectious diseases; these epidemics show
that animal reservoirs are important sources of new infec-
tious threats to humans. Contact between humans and ani-
mals is a crucial rate-limiting step in this process, although
data describing the variables that influence animal-to-
human transmission are relatively scarce. Nonhuman pri-
mates, by virtue of their genetic, physiologic, and
sometimes social similarities to humans, are particularly
likely sources of infectious agents that pose a threat to
humans (1,2). Data on simian immunodeficiency virus
(SIV)/HIV dramatize this point; scientists now theorize
that SIVs were transmitted from primates to humans on
several occasions (3,4). As a result, concern is increasing
that other infectious agents enzootic in primate popula-
tions may endanger humans (5). 
The family of SIV is 1 of 4 primateborne retroviruses
known to infect humans (6). Simian T-cell lymphotropic
viruses, enzootic in both Asian and African Old World
monkeys and apes, may have repeatedly crossed the
species barrier (7,8). The resulting human form of the
virus, HTLV, is the etiologic agent of 2 human diseases,
adult T-cell leukemia and tropical spastic paresis (9).
Serologic studies have demonstrated evidence of primate-
to-human transmission of simian retrovirus (SRV), a retro-
virus enzootic among Old World monkeys, in laboratory
workers exposed to captive primates (10). To date, no dis-
ease has been linked to human infection with SRV. Finally,
in the past decade, evidence of infection with simian
foamy virus (SFV) has been identified in 1% to 4% of per-
sons who come into frequent contact with primates in zoos
and primate laboratories and among 1% of bushmeat
hunters in Central Africa (11–15). 
SFV 
SFVs are exogenous retroviruses enzootic in both New
and Old World primates (16–18). Phylogenetic analyses of
SFVs indicate a species-specific distribution of virus
strains not unlike that of SIV among some African primate
species (19–23). Among captive primate populations, sero-
prevalence of antibodies to SFVmay reach 100% in adults,
with many animals seroconverting before the onset of sex-
ual maturity (19,24; J. Allan, unpub. data). Fewer data are
available on the seroprevalence of antibodies to SFV
among free-ranging populations of primates. SFV is pres-
ent in highest concentrations in the saliva of infected labo-
ratory macaques (Macaca mulatta and M. fascicularis) and
African green monkeys (Cercopithecus aethiops), which
suggests that bites, scratches, and mucosal splashes with
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Because SFV is not known to occur naturally in
humans, detecting serologic or molecular evidence, or
both, of infection in a human, along with a history of close
contact with primates, constitutes strong evidence for pri-
mate-to-human transmission, i.e., a marker for cross-
species transmission (28). Existing serologic and
molecular techniques can sensitively and specifically
detect human SFV infections (29).
Primates and humans come into contact in a variety of
contexts in Asia, including owning primate pets, observing
performance monkeys, participating in ecotourism activi-
ties, hunting primates for bushmeat, and visiting monkey
temples (30,31). Monkey temples are religious sites that
have, over time, become associated with populations of
free-ranging primates. Monkey temples are common
throughout southern and Southeast Asia, where primates
play an important role in culture. Asia’s monkey temples
annually bring millions of people, including hundreds of
thousands of tourists, from around the world into close
proximity with free-ranging primates (32–34). Worldwide,
monkey temples may account for more human-primate
contact than any other context. 
In Bali, ≈45 temple sites contain substantial popula-
tions of free-ranging macaques (33). Those who spend the
most time in or around monkey temples include workers
who maintain the temples; nuns, monks, and others who
live on or around temple grounds; merchants who sell a
variety of goods to tourists; and farmers whose fields are
raided by macaques. Worshippers and tourists may also
come into contact with temple macaques. These temples
are thus an important context in which to investigate cross-
species transmission of infectious agents.
Serologic data on free-ranging Southeast Asian
macaques, though incomplete, suggest that SFV is enzoot-
ic among these macaque populations and that correspon-
ding rates of SFV infection are high (80%–100%) (L.
Jones-Engel, unpub. data). We hypothesized that humans
who come into contact with these macaques might similar-
ly show evidence of infection with SFV and investigated
this proposition among a group of persons who worked at
or around the Sangeh monkey temple in Bali, Indonesia.
Methods
Study Site: Sangeh Monkey Temple
The Sangeh monkey temple is in central Bali,
Indonesia, ≈20 km north of Denpasar, Bali’s most popu-
lous city. The 17th-century Hindu temple complex at
Sangeh serves the surrounding community and is a popu-
lar domestic and international tourist destination.
Approximately 200 free-ranging M. fascicularis roam
throughout the 6-hectare temple complex and into the sur-
rounding rice fields and farms. Most of the macaques’
caloric intake is from daily provisions provided by temple
workers and food given to them by visitors. 
Human Participant Sampling
In July 2000, as part of a larger study on the epidemiol-
ogy of exposure to primateborne viruses at the Sangeh
monkey temple, 82 workers from Sangeh agreed to partic-
ipate in the present study (32). After informed consent was
obtained, a questionnaire designed to elicit demographic
data as well as data describing the frequency and type of
exposure to Sangeh’s macaques was administered in
Bahasa Indonesia, the national language of Indonesia. Sub-
sequently, 10 mLof blood was withdrawn from each partic-
ipants antecubital vein, 6 mL was centrifuged to extract
serum, and the remainder was mixed with EDTA. Serum
specimens and whole blood were then stored at –20°C. 
Macaque Sampling
In July 2000, 38 macaques within the Sangeh monkey
temple area and surrounding forest were darted oppor-
tunistically and sedated with 3 mg/kg of Telazol (tileta-
mine HCl/zolazepam HCl). Following universal
precautions, researchers withdrew 10 mL of blood from
each macaque’s femoral vein. The macaques were closely
monitored during anesthesia and recovery. Six milliliters
of blood was placed in a serum separator tube and cen-
trifuged in the field to extract the serum. The remaining
blood was placed in a tube containing EDTA. Sera and
whole blood were frozen and stored at –20°C. 
Western Blot Analysis 
Western blot immunoassays were performed with a few
modifications (21). Briefly, human foreskin fibroblast cells
were infected with SFVbab1 (an isolate from a baboon)
and maintained until notable cytopathologic changes were
observed (19). Culture supernatant fluid containing virus
was harvested, and SFV was purified through a 20%
sucrose cushion, separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis, and the antigens were
blotted onto nitrocellulose sheets. The nitrocellulose paper
was blocked with 3% bovine serum albumin and subse-
quently incubated with serum at a dilution of 1:40. Viral
proteins were detected with the streptavidin-biotin system
(Amersham Inc., Arlington Heights, IL, USA) by using
diaminobenzidine as the substrate for color development.
The criterion used for a positive sample was antibody reac-
tivity to both p70 and p74 gag-related proteins (19).
PCR Detection of SFV 
DNA was purified from whole blood by using the
QIAamp DNA Blood Mini Kit (Qiagen, Inc., Valencia,
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were combined with 200 µL whole blood and incubated at
56°C for 10 min. After incubation, 200 µL ethanol was
added, and the entire mixture was applied to a QIAamp
spin column. The purified DNA was eluted from the col-
umn with 70 µL nuclease-free water, and concentration
was determined spectrophotometrically at optical density
260 nm.
The presence of SFV DNA was determined by using
nested PCR. Five hundred ng purified DNAwas combined
with a PCR reaction mixture with a final concentration of
10 mmol/L Tris (pH 9.0), 50 mmol/L KCl, 0.1% Triton X-
100, 2 mmol/L MgCl2, 200 µmol/L each dNTP, 0.15
mg/mL BSA, 1 µm Taq polymerase, and 400 nmol/L of
each primer in a total volume of 50 µL. The following
primer pairs were used: first round, forward 5′ CAG TGA
ATT CCAGAATCT CTT C 3′, reverse 5′ CAC TTATCC
CAC TAG ATG GTT C 3′; and second round, forward 5′
CCA GAA TCT CTT CAT ACT AAC TA 3′, reverse 5′
GAT GGT TCC CTAAGC AAG GC 3′ (29). “Touchdown
PCR” was used for both rounds with reaction conditions of
initial denaturation at 94°C for 2 min, followed by 7 cycles
of 94°C for 30 s, 60°C for 30 s, and 72°C for 45 s, with a
2°C decrease in annealing temperature per cycle to 48°C,
followed by 33 cycles of 94°C for 30 s, 48°C for 30 s, and
72°C for 45 seconds with a final extension at 72°C for 2
min. Second-round conditions were the same, except 19
cycles were used instead of 33.
Twenty µLof the PCR reaction underwent electrophore-
sis on a 1% low melting point agarose gel. DNA bands
(365-bp product) were excised from the gel and purified by
using Wizard PCR Preps DNA Purification System
(Promega Corp., Madison, WI, USA). The PCR product
was ligated into the pCR 2.1-TOPO vector by using the
TOPO TA Cloning Kit (Invitrogen Corp., Carlsbad, CA,
USA.). An SFV DNA plasmid (pSFV-1Lgp), representing
long terminal repeat, gag, and pol of SFV-1,  was included
as a positive PCR control and for determining sensitivity of
detection by serial dilution (provided by A. Mergia).
TOP10 cells were transformed with the ligation reaction,
plated onto Luria broth agar plates containing 50 µg/mL
kanamycin, and incubated overnight at 37°C. Miniscreen
DNA was purified by using Wizard Plus Minipreps DNA
Purification System (Promega). Samples were sequenced
with the ABI 373 automated fluorescent sequencer using
BigDye Terminator cycle sequencing chemistry (Applied
Biosystems, Foster City, CA, USA).
Amplification of Mitochondrial Sequences
Five hundred ng purified DNA from whole blood was
combined in a PCR reaction mixture with a final concen-
tration of 10 mmol/L Tris (pH 9.0), 50 mmol/L KCl, 0.1%
Triton X-100, 2.5 mmol/L MgCl2, 200 µmol/L each dNTP,
0.15 mg/mLBSA, 1 U Taq polymerase, and 400 nmol/Lof
each primer in a total volume of 50 µL. The following
primers were used: forward, 12SA, 5´ CTG GGA TTA
GAT ACC CAC TAT 3´, and reverse, 12SO, 5´ GTC GAT
TATAGG ACA GGT TCC TCTA 3´ (35). Cycling condi-
tions were the following: initial denaturation at 94°C for 5
min, followed by 35 cycles of 94°C for 30 s, 55°C for 30
s, and 72°C for 5 min, with a final extension at 72°C for 5
min. The 101-bp product underwent electrophoresis and
was processed for DNA sequencing essentially as
described for SFV. 
The alignments were made in Bioedit (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html) and ClustalX 1.81
(ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX/). Columns in
the alignment in which gaps had been inserted in regions
with insertions, and deletions were stripped before the
analyses. DNA trees were created with the neighbor-join-
ing method by using the Phylip program (DNAdist;
Neighbor), and the output was generated with Treeview
(http://taxonomy. zoology.gla.ac.uk/rod/treeview.html).
The GenBank accession numbers for the SFV and mito-
chondrial DNA sequences reported here are AY628152-69
and AY633510-39, respectively.
Results
Seroprevalence of SFV among Macaques
The seroprevalence of SFV among the Sangeh
macaques is presented in Table 1. Thirty-eight macaques
(29 males and 9 females; 4 juveniles, 6 subadults, 28
adults) were sampled. Thirty-four (89.5%) of the 38
macaques were seropositive for SFV by Western blot; 2
(50%) of 4 juveniles, all 6 (100%) subadults, and 26 (93%)
of the adults were antibody positive. All 9 females were
SFV seropositive. SFV seroprevalence in this free-ranging
macaque population was consistent with seroprevalence
studies done in captive (25) and other free-ranging
macaque populations (L. Jones-Engel, unpub. data).
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Nearly two thirds of the study sample was male
(62.2%), and the mean age of the study participants was 35
years (Table 2). Of participants who reported being
exposed, 23 (28.0%) of 82 persons reported having been
bitten by the temple’s macaques (Table 3). Five of the 23
reported being bitten more than once. Thirty-one (37.8%)
of 82 reported having been scratched, including 9 persons
who had been scratched more than once. In total, 37
(45.1%) of 82 reported having been either bitten or
scratched.
Of the 82 persons whose serum was tested for antibod-
ies to SFV, 81 had negative results by Western blot. Serum
from a 47-year-old farmer (BH66) was reactive to SFV
gag proteins, p70/p74 (Figure 1). This man reported that he
visited the monkey temple every day and had previously
been bitten once and scratched on more than one occasion
by macaques there. He reported that the bite and scratches,
which occurred on his hands and toes, had bled and that he
had washed the wounds and applied traditional medicines.
He denied owning or coming into contact with a pet pri-
mate. He also denied hunting primates or consuming pri-
mate meat.
Detection of SFV DNA in a Person from Bali 
To determine whether SFV was present in humans and
macaques, we performed nested PCR amplification of
SFV by using conserved primers designed to detect
macaque SFV (29). SFV was detected in the macaques
tested, as well as in the 1 human participant (BH66),
whose serum contained antibodies to SFV. Blood samples
from all 81 human participants that were seronegative for
antibodies to SFV were also negative for SFV by PCR.
The limits of sensitivity for nested PCR were 1–10 SFV
DNA copies per 500 ng cellular DNA, as determined by
dilution of a positive control plasmid.
Quantitative PCR products of BH66, 5 of the Sangeh
macaques (M.  fascicularis), and 13 pet macaques (M.
tonkeana, M. maura, and M. fascicularis) from Sulawesi,
Indonesia, were cloned at least twice, sequenced, and com-
pared with published sequences from a rhesus macaque
(M. mulatta) (SFV-1mac, M55279), an African green mon-
key (Cercopithecus aethiops) (SFV-3agm, M74895), and a
chimpanzee (Pan troglodytes) (SFVcpz, U04327). As
shown in Figure 2, SFV from BH66 was most closely
related to an SFV sequence amplified from 1 of the
macaques at the Sangeh Monkey Temple (BP6). To verify
that the BH66 sample was of human origin and not a mis-
labeled sample from an SFV-infected monkey, we ampli-
fied a small fragment from the 12S ribosomal
mitochondrial DNA from 2 healthy unexposed humans,
BH66, several macaque species, and African green mon-
keys; cloned the products; and derived DNA sequences.
Phylogenetic analysis (Figure 3) showed that the human
DNA sample grouped with mitochondrial DNA sequences
from humans, confirming that the BH66 sample was from
a human. Lymphocytes from BH66 were not available for
isolation of SFV directly. 
Discussion
Human Infection with SFV at the 
Sangeh Monkey Forest
This report documents the first case of SFV infection
in a person with known exposure to free-ranging Asian
primates. Antibodies to SFV were detected in serum, and
SFV genomic segments were amplified from blood of the
infected person. Because PCR is prone to contamination,
which leads to false-positive results, PCR products were
sequenced and compared to SFV from other macaque
species. Phylogenetic analysis showed that SFV amplified
from the infected human was most similar to SFV from M.
fascicularis at the Sangeh monkey temple. Although
ascertaining exactly how or when the person acquired his
infection was not possible, he did report having been bit-
ten once and scratched on a number of occasions by
macaques at Sangeh. He denied other past contacts with
primates. 
Because only 1 infected person was detected and our
sample size was limited (82 persons), we cannot estimate
the prevalence of SFV infection in this human sample.
Previous research on naturally acquired SFV infection
among bushmeat hunters in Central Africa found 10 who
seroconverted in a population of 1,099 (1%), of which 3
also had positive results by PCR. Surveillance of larger
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temples is necessary to estimate the risk of SFV infection
in this context.
Monkey Temples in Bali as Contexts 
for Primate-Human Contact
Human and macaque sympatry in Southeast Asia dates
back as far as 25,000 years, as evidenced by remains at
Niah Cave in Borneo (37). Hindu and Buddhist temples are
a relatively recent addition to the landscape, first appearing
1,000 to 4,000 years ago. Contemporary human-macaque
commensalism at each monkey temple is shaped by the
behavioral characteristics of the particular monkey popula-
tion as well as the community’s unique geographic, social,
religious, and economic factors. Human-macaque contact
differs at the various monkey temples. At Sangeh, where
tourism has become an important economic resource,
macaques depend on visitor feeding for most of their nutri-
tion and have learned to climb on visitors’heads and shoul-
ders to obtain food. Local photographers, who make a
living photographing visitors with monkeys, encourage this
behavior. Macaques, sometimes provoked by visitors, can
become aggressive and will bite or scratch people.
The Sangeh Temple Committee, which manages the
Sangeh Monkey Forest, estimates ≈250 persons work in
and around the monkey forest. Of the 82 persons who par-
ticipated in the present study, 28% had been bitten by a
macaque, and 6% had been bitten more than once. In com-
parison, 700,000 tourists visit the 4 main monkey temples
on the island of Bali (Padangtegal/Ubud, Sangeh, Alas
Kedaton, and Uluwatu) annually and as many as 5% of
these visitors are bitten by macaques (A. Fuentes, unpub.
data). These data suggest that visitors receive the prepon-
derance of macaque bites. 
Importance of SFV Infection in Humans
The literature describes ≈40 cases of human infection
with SFV. Long-term follow-up data are unavailable for
many of these cases. However, no disease has been linked
to SFV among infected humans. Furthermore, no cases of
human-to-human transmission have been described, even
among those receiving transfusions of blood products from
a worker at a primate center who was later shown to be
infected with SFV (38). 
Notwithstanding, more data are needed before SFV can
be proclaimed a “virus without a disease.” First, SFV
infection has not been extensively studied in immunocom-
promised persons, so whether SFV has a more aggressive
course in an immunologically “permissive” environment is
unknown. Two persons died shortly after receiving baboon
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Figure 1. Western blot analysis of human serum samples for evi-
dence of simian foamy virus (SFV) antibodies. Antibodies to the
gag precursor proteins (p70/p74) were apparent from the human
BH66 blood sample, which indicated infection with SFV. Positive
control is an SFV-infected baboon.
Figure 2. Phylogenetic analysis of simian foamy virus (SFV) DNA
from several species of Indonesian primates and an infected
human. BP 2, 5, and 6 represent Sangeh monkey temple
macaques (Macaca fascicularis). P 18, 19, 27, 32, 37, 66, 67, and
70 are pet macaques (M. tonkeana) from Sulawesi, Indonesia.
P48, 49 and 72 are pet macaques (M. maura) from Sulawesi,
Indonesia. P75 is a pet M. fascicularis macaque from Sulawesi,
Indonesia. All Sulawesi pet primate samples were collected during
2000. SFV-1mac represents a published sequence from a rhesus
macaque (M. mulatta), and SFV-3agm is a published sequence
from an African green monkey (Cercopithecus aethiops). SFVcpz
is a published sequence from a chimpanzee (Pan troglodytes) and
was used an outgroup for this tree. The SFV human strain (BH66)
clustered with an SFV sequence amplified from BP6 one of the
macaques at the Sangeh monkey temple. The SFV DNA tree was
created with the neighbor-joining method by using the PHYLIP
program (DNAdist; Neighbor). Bootstrap replicates were 1,000.
Bootstrap values were calculated by using Seqboot, DNAdist,
Neighbor, and Consense (PHYLIP programs). Bootstrap values
60% are shown. The SFV tree was plotted in Treeview.liver transplants in 1994, and SFV was detected in the
blood and tissues of both at autopsy (39). More research in
this area is needed. Moreover, little is known about the epi-
zootiology of SFV among wild primates. Although SFV
infection in humans has not culminated in any observable
symptoms, SFV strains may differ in their capacity to
infect or cause disease in humans. Finally, whether SFV
can adapt in humans after transmission and potentially lead
to disease needs to be examined.
Implications and Recommendations for Public Health
The recent SARS epidemic vividly demonstrates how
the economic infrastructure and dense population of Asia
facilitate the rapid international spread of disease. The
combination of large primate reservoirs, prevalent human-
primate contact, a growing immunocompromised popula-
tion, and advanced infrastructure in Asia increases the
likelihood of a primateborne zoonosis emerging on this
continent.
The demonstration of SFV transmission in the context
of a monkey temple in Bali points to a broad public health
concern: other enzootic primate infectious agents may
cross the species barrier and cause significant morbidity
and mortality in human populations. Given our lack of
knowledge of the effects of SFV, as well as the poorly
defined risk of other primateborne zoonoses, steps should
be taken to decrease the risks of cross-species transmission
among the many persons who visit these sites. Previous
data on both worker and visitor exposure to macaques at
monkey temples suggest that human behaviors, especially
the practice of feeding macaques, is a risk factor for being
bitten or scratched (33,34). We have recommended that
monkeys be fed only by specially trained personnel who
minimize physical contact with monkeys. Such restrictions
have been successfully employed at other monkey forests
in Asia. For example, Singapore’s Bukit Timah Nature
Reserve has nearly 200 free-ranging macaques (M. fascic-
ularis), and in 2002, an estimated 380,000 visitors made
use of the reserve’s trail system, yet contact between mon-
keys and visitors at Bukit Timah is rare. This finding may
be ascribed to the park’s policy, enforced by stiff fines, of
prohibiting visitors from feeding macaques. 
Conclusions
This study reports the first case of human SFVinfection
in Asia and also, for the first time, links natural transmis-
sion of SFV to a person to a specific population of pri-
mates. Our findings suggest that workers in and around
monkey temples can become infected with SFV. By impli-
cation, visitors to monkey temples, especially those who
are bitten by a macaque, may also be at risk for SFV infec-
tion. Because many visitors to monkey temples are inter-
national travelers, these findings have ramifications for the
potential global spread of primateborne infectious agents.
Demonstrating natural cross-species transmission in a con-
text that does not involve hunting for bushmeat implies
that other contexts of primate-human contact may also
facilitate the transmission of simian pathogens. These data
point to the need for further research into SFV transmis-
sion in other contexts, including pet ownership and per-
formance animals, as well as in the diverse geographic
areas where humans and primates come into contact. Such
research will help describe the overall picture of the
Primate-to-Human Retroviral Transmission in Asia
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Figure 3. Phylogenetic analysis of mitochrondrial (mt) DNA from
nonhuman primates and humans. mtDNA was amplified and
sequenced from the simian foamy virus-infected person (BH66), 2
human controls (Hu702 and Hu715), M. mulatta (Rh15454,
18511,18512, 18513,18514,18515, 11363, 9649), M. fascicularis
(BP2, 4, 5, 6), M. nemestrina (P46), M. tonkeana (P18,39,40), M.
maura (P44, 73), M. nigra (P79, M1); M. nigrescens (M27, 28),
and M. hecki (M7). The mtDNA tree was created with the neigh-
bor-joining method with the Phylip program (DNAdist; Neighbor).
Bootstrap replicates were 1,000. Bootstrap values were calculated
by using Seqboot, DNAdist, Neighbor, and Consense (PHYLIP
programs). Bootstrap values >60% are shown. The mtDNA tree
was plotted in Treeview. This analysis suggests that BH66 was of
human origin. Although the phylogenetic tree constructed with
mtDNA from a variety of monkey samples can be used to distin-
guish human from monkey mtDNA, a large number of nuclear
mtDNA sequences, have evolved as pseudogenes (36). These
sequences can be highly divergent from mtDNA and resulted in
some ambiguity as mtDNAamplified from several monkeys did not
group with other members of the same species. Because of the
nature and variability of these sequences, definitive conclusions
about mtDNA phylogenies could not be determined; however,
mtDNA trees were still useful for determining the origin of mtDNA
material. emergence of primateborne pathogens such as HIV/SIV
and will form a scientific basis for guiding policies and
programs to deter the spread of emerging zoonotic
pathogens.
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